The emerging quest for the optimal angiostatic combination therapy - PubMed (original) (raw)

• Immunotherapeutic Targeting of Tumor-Associated Blood Vessels.
  Fabian KL, Storkus WJ. Fabian KL, et al. Adv Exp Med Biol. 2017;1036:191-211. doi: 10.1007/978-3-319-67577-0_13. Adv Exp Med Biol. 2017. PMID: 29275473 Review.
• Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy.
  Weiss A, Bonvin D, Berndsen RH, Scherrer E, Wong TJ, Dyson PJ, Griffioen AW, Nowak-Sliwinska P. Weiss A, et al. Sci Rep. 2015 Mar 11;5:8990. doi: 10.1038/srep08990. Sci Rep. 2015. PMID: 25758612 Free PMC article.
• Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expression.
  Berndsen RH, Castrogiovanni C, Weiss A, Rausch M, Dallinga MG, Miljkovic-Licina M, Klaassen I, Meraldi P, van Beijnum JR, Nowak-Sliwinska P. Berndsen RH, et al. Br J Cancer. 2019 Jul;121(2):139-149. doi: 10.1038/s41416-019-0498-2. Epub 2019 Jun 25. Br J Cancer. 2019. PMID: 31235865 Free PMC article.
• Consensus guidelines for the use and interpretation of angiogenesis assays.
  Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW. Nowak-Sliwinska P, et al. Angiogenesis. 2018 Aug;21(3):425-532. doi: 10.1007/s10456-018-9613-x. Angiogenesis. 2018. PMID: 29766399 Free PMC article. Review.
• Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line.
  Xu X, Yan Y, Xun Q, Shi J, Kong X, Wu J, Zhou H. Xu X, et al. Onco Targets Ther. 2019 Feb 14;12:1215-1223. doi: 10.2147/OTT.S194064. eCollection 2019. Onco Targets Ther. 2019. PMID: 30863089 Free PMC article. Retracted.